324905 Sigma-AldrichEpirubicin Hydrochloride - CAS 56390-09-1 - Calbiochem
A cell-permeable antitumor antibiotic.
More>> A cell-permeable antitumor antibiotic. Less<<Epirubicin Hydrochloride - CAS 56390-09-1 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Synonyms: 4ʹ-Epidoxorubicin, HCl
Recommended Products
Áttekintés
| Replacement Information |
|---|
Kulcsspecifikációk táblázata
| CAS # | Empirical Formula |
|---|---|
| 56390-09-1 | C₂₇H₂₉NO₁₁ · HCl |
| Description | |
|---|---|
| Overview | This product has been discontinued. A cell-permeable antitumor antibiotic. A stereoisomer of Doxorubicin (Cat. No. 324380) that exhibits reduced cardiotoxicity. Its antitumor actions are mediated by targeting topoisomerase II. |
| Catalogue Number | 324905 |
| Brand Family | Calbiochem® |
| Synonyms | 4ʹ-Epidoxorubicin, HCl |
| Product Information | |
|---|---|
| CAS number | 56390-09-1 |
| ATP Competitive | N |
| Form | Orange-red solid |
| Hill Formula | C₂₇H₂₉NO₁₁ · HCl |
| Chemical formula | C₂₇H₂₉NO₁₁ · HCl |
| Hygroscopic | Hygroscopic |
| Reversible | N |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | Antitumor antibiotic |
| Purity | ≥95% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS | |
|---|---|
| RTECS | QI9295750 |
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Katalógusszám | GTIN |
| 324905 | 0 |
Documentation
Epirubicin Hydrochloride - CAS 56390-09-1 - Calbiochem MSDS
| Title |
|---|
Epirubicin Hydrochloride - CAS 56390-09-1 - Calbiochem Certificates of Analysis
| Title | Lot Number |
|---|---|
| 324905 |
References
| Hivatkozások áttekintése |
|---|
| Luck, H.J., et al. 1996. Semin. Oncol. 23, 33. Sandri, M.I., et al. 1996. Br. J. Cancer 73, 1518. Boddy, A.V., et al. 1995. Eur. J. Cancer 31A, 69. Pouna, P., et al. 1995. Cancer. Chemother. Pharmacol. 35, 257. |